Company Filing History:
Years Active: 2019
Title: Exploring the Innovations of Annette Rømmelmayer Lundegaard
Introduction
Annette Rømmelmayer Lundegaard, based in Søborg, Denmark, is a notable inventor recognized for his contributions to the field of pharmaceuticals. With a focus on developing allergen dosage forms, Lundegaard has made significant strides in creating effective and innovative products that address allergy-related health concerns.
Latest Patents
Lundegaard holds a patent for an "Allergen dosage form," which provides allergen-containing pharmaceutical products, specifically geared towards fast-dispersing solid allergen dosage forms. The invention emphasizes the creation of non-compressed solid dosage forms suitable for oromucosal administration that includes a matrix and at least one allergen. The matrices identified for this innovation include gelatine, starch, and mannitol, alongside detailed methods pertaining to the dosage forms.
Career Highlights
Currently, Annette Rømmelmayer Lundegaard is associated with Alk-Abelló A/S, a renowned company specializing in allergy immunotherapy products. His work significantly contributes to the development of innovative allergy treatments, advancing the pharmaceutical landscape and enhancing patient care.
Collaborations
In his professional journey, Lundegaard collaborates closely with esteemed colleagues, including Henrik Hugo Jacobi and Christian Gauguin Houghton. Their combined expertise fosters a creative environment aimed at pushing the boundaries of pharmaceutical innovation and improving treatment efficacy for allergy sufferers.
Conclusion
Annette Rømmelmayer Lundegaard represents a growing wave of inventors dedicated to solving pressing health issues through innovation. His patented contributions to allergen dosage forms not only showcase his inventiveness but also highlight the collaborative efforts within the pharmaceutical industry, ultimately benefiting individuals with allergies.